$ELWS
Earlyworks Co., Ltd. Stock $elws

$elws Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 20-F Financial Statement

#000121390023077074 Filed on September 15, 2023

Income Statement

Concept	2023 Q2	2023	2022 Q2
Revenue	$46.57M	$342.4K	$463.7M
YoY Change	-89.96%	-99.93%
Cost Of Revenue	$30.50M	$224.3K	$108.4M
YoY Change	-71.86%	-99.79%
Gross Profit	$16.07M	$118.1K	$355.3M
YoY Change	-95.48%	-99.97%
Gross Profit Margin	34.5%	34.5%	76.63%
Selling, General & Admin	$295.7M	$2.174M	$901.7M
YoY Change	-67.21%	-99.76%
% of Gross Profit	1840.32%	1840.32%	253.76%
Research & Development	$108.8M	$800.2K	$25.75M
YoY Change	322.56%	-96.89%
% of Gross Profit	677.34%	677.34%	7.25%
Depreciation & Amortization	$454.4K	$5.725K	$185.2K
YoY Change	145.3%	-98.15%
% of Gross Profit	2.83%	4.85%	0.05%
Operating Expenses	$404.5M	$2.974M	$927.5M
YoY Change	-56.39%	-99.68%
Operating Profit	-$388.4M	-$2.856M	-$572.1M
YoY Change	-32.11%	-99.5%
Interest Expense	-$2.699M	$252.00	-$1.259M
YoY Change	114.44%	-100.02%
% of Operating Profit
Other Income/Expense, Net	$228.9K		-$155.4K
YoY Change	-247.29%
Pretax Income	-$391.5M	-$2.879M	-$573.5M
YoY Change	-31.73%	-99.5%
Income Tax	-$9.223M	-$67.82K	$28.94M
% Of Pretax Income
Net Earnings	-$382.3M	-$2.811M	-$602.5M
YoY Change	-36.54%	-99.53%
Net Earnings / Revenue	-820.95%	-820.95%	-129.92%
Basic Earnings Per Share		-$0.20
Diluted Earnings Per Share	-$25.42	-$0.20	-$40.06
COMMON SHARES
Basic Shares Outstanding	15.04M shares	13.84M shares
Diluted Shares Outstanding		13.84M shares

Balance Sheet

Concept	2023 Q2	2023	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$177.9M	$177.9M
YoY Change		-72.94%
Cash & Equivalents	$1.308M		657.4M jpies
Short-Term Investments
Other Short-Term Assets	$2.026K	$6.714M	329.9K jpies
YoY Change	-99.39%	-24.28%
Inventory
Prepaid Expenses	$19.06K		5.440M jpies
Receivables	$227.5K	$6.352M	72.26M jpies
Other Receivables	$43.73M	$43.73M
Total Short-Term Assets	$1.726M	$234.7M	738.5M jpies
YoY Change	-99.77%	-68.22%
LONG-TERM ASSETS
Property, Plant & Equipment	$15.20K	$5.534M	1.218M jpies
YoY Change	-98.75%	-56.96%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$212.8M	$212.8M
YoY Change		32755.45%
Total Long-Term Assets	$1.606M	$218.4M	13.51M jpies
YoY Change	-88.11%	1516.58%
TOTAL ASSETS
Total Short-Term Assets	$1.726M	$234.7M	738.5M jpies
Total Long-Term Assets	$1.606M	$218.4M	13.51M jpies
Total Assets	$3.331M	$453.0M	752.1M jpies
YoY Change	-99.56%	-39.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$48.21M	$48.21M
YoY Change		-19.59%
Deferred Revenue	1.397M jpies
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$123.8M	$123.8M
YoY Change		952.08%
Total Short-Term Liabilities	$1.295M	$176.1M	111.4M jpies
YoY Change	-98.84%	58.09%
LONG-TERM LIABILITIES
Long-Term Debt	$501.9K	$68.25M	46.32M jpies
YoY Change	-98.92%	47.35%
Other Long-Term Liabilities	$0.00	$0.00
YoY Change		-100.0%
Total Long-Term Liabilities	$501.9K	$68.25M	46.32M jpies
YoY Change	-98.92%	37.08%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.295M	$176.1M	111.4M jpies
Total Long-Term Liabilities	$501.9K	$68.25M	46.32M jpies
Total Liabilities	$1.798M	$244.5M	161.2M jpies
YoY Change	-98.88%	51.66%
SHAREHOLDERS EQUITY
Retained Earnings	-$11.72M		-1.268B jpies
YoY Change	-99.08%
Common Stock	$735.3K		334.6M jpies
YoY Change	-99.78%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.533M	$208.5M	$4.345M
YoY Change
Total Liabilities & Shareholders Equity	$3.331M	$453.0M	752.1M jpies
YoY Change	-99.56%	-39.76%

Cashflow Statement

Concept	2023 Q2	2023	2022 Q2
OPERATING ACTIVITIES
Net Income	-$382.3M	-$2.811M	-$602.5M
YoY Change	-36.54%	-99.53%
Depreciation, Depletion And Amortization	$454.4K	$5.725K	$185.2K
YoY Change	145.3%	-98.15%
Cash From Operating Activities	-$186.3M	-$2.939M	$110.1M
YoY Change	-269.24%	-102.93%
INVESTING ACTIVITIES
Capital Expenditures	$990.2K	$11.97K	$751.8K
YoY Change	31.72%	-98.78%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$187.0K
YoY Change	-100.0%	-100.0%
Cash From Investing Activities	-$990.2K	-$11.97K	-$564.8K
YoY Change	75.33%	-100.32%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00	$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-101.5M	-$576.6K	-6.000M
YoY Change	1591.01%	-100.3%
NET CHANGE
Cash From Operating Activities	-186.3M	-$2.939M	110.1M
Cash From Investing Activities	-990.2K	-$11.97K	-564.8K
Cash From Financing Activities	-101.5M	-$576.6K	-6.000M
Net Change In Cash	-288.8M	-$3.526M	103.5M
YoY Change	-378.93%	-101.2%
FREE CASH FLOW
Cash From Operating Activities	-$186.3M	-$2.939M	$110.1M
Capital Expenditures	$990.2K	$11.97K	$751.8K
Free Cash Flow	-$187.3M	-$2.951M	$109.3M
YoY Change	-271.31%	-102.97%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Type DocumentType	20-F
CY2023	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-04-30
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--04-30
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-41752
CY2023	dei	Entity Registrant Name EntityRegistrantName	Earlyworks Co., Ltd.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	M0
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	5-7-11
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Ueno
CY2023	dei	Entity Address Address Line3 EntityAddressAddressLine3	Taito-ku
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Tokyo
CY2023	dei	Entity Address Country EntityAddressCountry	JP
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	110-0005
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	15039400	shares
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023	dei	Auditor Name AuditorName	WWC, P.C.
CY2023	dei	Auditor Firm AuditorFirmId	1171
CY2023	dei	Auditor Location AuditorLocation	San Mateo, California
CY2022Q2	us-gaap	Cash Cash	657418101	jpy
CY2023Q2	us-gaap	Cash Cash	177886393	jpy
CY2023Q2	us-gaap	Cash Cash	1308085	usd
CY2023Q2	elws	Digital Assets DigitalAssets	750307	jpy
CY2023Q2	elws	Digital Assets DigitalAssets	5517	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	72259707	jpy
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	30934916	jpy
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	227479	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	5440044	jpy
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2591297	jpy
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	19055	usd
CY2022Q2	us-gaap	Deposits Assets Current DepositsAssetsCurrent	3096564	jpy
CY2023Q2	us-gaap	Deposits Assets Current DepositsAssetsCurrent	3096509	jpy
CY2023Q2	us-gaap	Deposits Assets Current DepositsAssetsCurrent	22770	usd
CY2023Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	19147994	jpy
CY2023Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	140805	usd
CY2022Q2	us-gaap	Other Assets Current OtherAssetsCurrent	329946	jpy
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	275577	jpy
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	2026	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	738544362	jpy
CY2023Q2	us-gaap	Assets Current AssetsCurrent	234682993	jpy
CY2023Q2	us-gaap	Assets Current AssetsCurrent	1725737	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1218085	jpy
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2067013	jpy
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15200	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	11641238	jpy
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3467368	jpy
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	25497	usd
CY2023Q2	us-gaap	Deferred Costs DeferredCosts	212160121	jpy
CY2023Q2	us-gaap	Deferred Costs DeferredCosts	1560116	usd
CY2022Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	647740	jpy
CY2023Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	657740	jpy
CY2023Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	4836	usd
CY2022Q2	us-gaap	Assets Assets	752051425	jpy
CY2023Q2	us-gaap	Assets Assets	453035235	jpy
CY2023Q2	us-gaap	Assets Assets	3331386	usd
CY2022Q2	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	11769000	jpy
CY2023Q2	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	123819000	jpy
CY2023Q2	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	910501	usd
CY2022Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	52825211	jpy
CY2023Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	47250464	jpy
CY2023Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	347456	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	8228038	jpy
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3467368	jpy
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	25497	usd
CY2022Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	38554097	jpy
CY2023Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	145000	jpy
CY2023Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	1066	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1397470	jpy
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10276	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	111376346	jpy
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	176079302	jpy
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1294796	usd
CY2022Q2	us-gaap	Long Term Loans From Bank LongTermLoansFromBank	46321500	jpy
CY2023Q2	us-gaap	Long Term Loans From Bank LongTermLoansFromBank	68252500	jpy
CY2023Q2	us-gaap	Long Term Loans From Bank LongTermLoansFromBank	501894	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3467368	jpy
CY2022Q2	elws	Deferred Tax Liabilitie Noncurrent DeferredTaxLiabilitieNoncurrent	66235	jpy
CY2023Q2	elws	Deferred Tax Liabilitie Noncurrent DeferredTaxLiabilitieNoncurrent	188496	jpy
CY2023Q2	elws	Deferred Tax Liabilitie Noncurrent DeferredTaxLiabilitieNoncurrent	1386	usd
CY2022Q2	us-gaap	Liabilities Liabilities	161231449	jpy
CY2023Q2	us-gaap	Liabilities Liabilities	244520298	jpy
CY2023Q2	us-gaap	Liabilities Liabilities	1798076	usd
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	55300000	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	55300000	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	55300000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13839400	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13839400	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13839400	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13839400	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13839400	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13839400	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	334575200	jpy
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	100000000	jpy
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	735348	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1524575200	jpy
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1702120099	jpy
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	12516509	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1268330424	jpy
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1593605162	jpy
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11718547	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	590819976	jpy
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	208514937	jpy
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	1533310	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	752051425	jpy
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	453035235	jpy
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3331386	usd
CY2021	us-gaap	Revenues Revenues	216211448	jpy
CY2022	us-gaap	Revenues Revenues	463718851	jpy
CY2023	us-gaap	Revenues Revenues	46568529	jpy
CY2023	us-gaap	Revenues Revenues	342441	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	33542166	jpy
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	108379683	jpy
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	30502236	jpy
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	224298	usd
CY2021	us-gaap	Gross Profit GrossProfit	182669282	jpy
CY2022	us-gaap	Gross Profit GrossProfit	355339168	jpy
CY2023	us-gaap	Gross Profit GrossProfit	16066293	jpy
CY2023	us-gaap	Gross Profit GrossProfit	118143	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	41985446	jpy
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	29727815	jpy
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	55667926	jpy
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	409354	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	150918716	jpy
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	201976446	jpy
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	240003326	jpy
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1764860	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	56000000	jpy
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	670000000	jpy
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	22893105	jpy
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	25753717	jpy
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	108823664	jpy
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	800232	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	271797267	jpy
CY2022	us-gaap	Operating Expenses OperatingExpenses	927457978	jpy
CY2023	us-gaap	Operating Expenses OperatingExpenses	404494916	jpy
CY2023	us-gaap	Operating Expenses OperatingExpenses	2974446	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-89127985	jpy
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-572118810	jpy
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-388428623	jpy
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-2856303	usd
CY2021	elws	Government Subsidies GovernmentSubsidies	4776746	jpy
CY2023	elws	Loss On Digital Assets LossOnDigitalAssets	629195	jpy
CY2023	elws	Loss On Digital Assets LossOnDigitalAssets	4627	usd
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1448138	jpy
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1258722	jpy
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2699144	jpy
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-19848	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	99841	jpy
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-155434	jpy
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	228943	jpy
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1684	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-440272	jpy
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-86139808	jpy
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-573532966	jpy
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-391528019	jpy
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2879094	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	290000	jpy
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	12963341	jpy
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-9345241	jpy
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-68720	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-15912026	jpy
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	15978261	jpy
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	122261	jpy
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	899	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-15622026	jpy
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	28941602	jpy
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-9222980	jpy
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-67821	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-70517782	jpy
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-602474568	jpy
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-382305039	jpy
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-2811273	usd
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.26
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-43.62
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-27.62
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.2
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.26
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-43.62
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-27.62
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.2
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13811305	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13839400	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13839400	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13811305	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13839400	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13839400	shares
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	234160326	jpy
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	1721893	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	103518000	jpy
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	761218	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-70517782	jpy
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-518551	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	56000000	jpy
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	411795	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	323160544	jpy
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	2376355	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	200134000	jpy
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1471682	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-602474568	jpy
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-4430286	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	670000000	jpy
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	4926832	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	590819976	jpy
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	4344583	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-382305039	jpy
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-2811273	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	208514937	jpy
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	1533310	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-70517782	jpy
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-602474568	jpy
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-382305039	jpy
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-2811273	usd
CY2021	us-gaap	Depreciation Depreciation	67932	jpy
CY2022	us-gaap	Depreciation Depreciation	309508	jpy
CY2023	us-gaap	Depreciation Depreciation	778611	jpy
CY2023	us-gaap	Depreciation Depreciation	5725	usd
CY2021	us-gaap	Loan Processing Fee LoanProcessingFee	244393	jpy
CY2022	us-gaap	Loan Processing Fee LoanProcessingFee	244233	jpy
CY2023	us-gaap	Loan Processing Fee LoanProcessingFee	231000	jpy
CY2023	us-gaap	Loan Processing Fee LoanProcessingFee	1699	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-15912026	jpy
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	15978261	jpy
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	122261	jpy
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	899	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Before Tax ForeignCurrencyTransactionGainBeforeTax	243159	jpy
CY2023	us-gaap	Foreign Currency Transaction Gain Before Tax ForeignCurrencyTransactionGainBeforeTax	1787	usd
CY2023	elws	Loss On Digital Assets LossOnDigitalAssets	629195	jpy
CY2023	elws	Loss On Digital Assets LossOnDigitalAssets	4627	usd
CY2023	elws	Realized Fair Value Gain On Digital Assets RealizedFairValueGainOnDigitalAssets	3412	jpy
CY2023	elws	Realized Fair Value Gain On Digital Assets RealizedFairValueGainOnDigitalAssets	25	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-440272	jpy
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	56000000	jpy
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	670000000	jpy
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-54368059	jpy
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	31572765	jpy
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-41324791	jpy
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-303880	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	2573645	jpy
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1083020	jpy
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-2848747	jpy
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-20948	usd
CY2022	elws	Increase Decrease Shortterm Deposits IncreaseDecreaseShorttermDeposits	3096564	jpy
CY2023	elws	Increase Decrease Shortterm Deposits IncreaseDecreaseShorttermDeposits	-55	jpy
CY2023	elws	Increase Decrease In Digital Assets IncreaseDecreaseInDigitalAssets	1382914	jpy
CY2023	elws	Increase Decrease In Digital Assets IncreaseDecreaseInDigitalAssets	10169	usd
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-1368080	jpy
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	87296	jpy
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-54369	jpy
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-399	usd
CY2023	elws	Increase Decrease Longterm Deposits IncreaseDecreaseLongtermDeposits	10000	jpy
CY2023	elws	Increase Decrease Longterm Deposits IncreaseDecreaseLongtermDeposits	74	usd
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	664195	jpy
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	28148718	jpy
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-57557091	jpy
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-423245	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	108544	jpy
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-108544	jpy
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1397470	jpy
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	10276	usd
CY2021	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	10263729	jpy
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	24000359	jpy
CY2023	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-5574747	jpy
CY2023	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-40994	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	8366	jpy
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-54168	jpy
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-396	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	34521751	jpy
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	100266688	jpy
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-399737207	jpy
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2939460	usd
CY2022	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	4559728	jpy
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	611152	jpy
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	984370	jpy
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1627539	jpy
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	11968	usd
CY2022	elws	Refund Of Security Deposit RefundOfSecurityDeposit	187000	jpy
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-611152	jpy
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	3762358	jpy
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1627539	jpy
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11968	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	103518000	jpy
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	200134000	jpy
CY2023	us-gaap	Payments For Proceeds From Deposit On Loan PaymentsForProceedsFromDepositOnLoan	-150000000	jpy
CY2023	us-gaap	Payments For Proceeds From Deposit On Loan PaymentsForProceedsFromDepositOnLoan	-1103023	usd
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	12000000	jpy
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt	11000000	jpy
CY2023	us-gaap	Repayments Of Debt RepaymentsOfDebt	16250000	jpy
CY2023	us-gaap	Repayments Of Debt RepaymentsOfDebt	119494	usd
CY2023	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering	212160121	jpy
CY2023	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering	1560116	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	91518000	jpy
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	189134000	jpy
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-78410121	jpy
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-576587	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	243159	jpy
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1787	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	125428599	jpy
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	293163046	jpy
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-479531708	jpy
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3526228	usd
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	238826456	jpy
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	364255055	jpy
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	657418101	jpy
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4834313	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	364255055	jpy
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	657418101	jpy
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	177886393	jpy
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1308085	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	1219532	jpy
CY2022	us-gaap	Interest Paid Net InterestPaidNet	1032588	jpy
CY2023	us-gaap	Interest Paid Net InterestPaidNet	2479492	jpy
CY2023	us-gaap	Interest Paid Net InterestPaidNet	18233	usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	173900	jpy
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	290000	jpy
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	22619600	jpy
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	166333	usd
CY2021	elws	Liabilities Assumed In Connection With Purchase Of Property And Equipment LiabilitiesAssumedInConnectionWithPurchaseOfPropertyAndEquipment	163408	jpy
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Note 1 – Nature of business and organization</b></p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Earlyworks Co., Ltd. (the “Company”) is a stock company incorporated in Japan pursuant to the laws of Japan on May 1, 2018. The Company builds products, delivers services, and develops solutions based on its proprietary Grid Ledger System to leverage blockchain technology in various business settings, including advertisement tracking, online visitor management, and sales of non-fungible tokens. The Company primarily generates revenue from software and system development services, consulting and solution services.</p>
CY2023	us-gaap	Substantial Doubt About Going Concern Conditions Or Events SubstantialDoubtAboutGoingConcernConditionsOrEvents	one
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-399737207	jpy
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2939460	usd
CY2023	elws	Working Capital WorkingCapital	58603691	jpy
CY2023	elws	Working Capital WorkingCapital	430941	usd
CY2023Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	177886393	jpy
CY2023Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	1308085	usd
CY2023	us-gaap	Demutualization By Insurance Entity Securities Issued Gross Cash Proceeds DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds	6	usd
CY2023Q2	elws	Accrued Outsourced Development Costs Current And Noncurrent AccruedOutsourcedDevelopmentCostsCurrentAndNoncurrent	6276121	jpy
CY2023Q2	elws	Accrued Outsourced Development Costs Current And Noncurrent AccruedOutsourcedDevelopmentCostsCurrentAndNoncurrent	46152	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration:underline">Use of estimates and assumptions</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the balance sheet date and revenues and expenses during the reporting periods. Significant accounting estimates reflected in the Company’s financial statements include, but not limited to, estimates for useful lives and impairment of property and equipment, impairment of long-lived assets, allowance for doubtful accounts, revenue recognition, and deferred taxes. Changes in facts and circumstances may result in revised estimates. Actual results could differ from those estimates, and as such, differences may be material to the financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The COVID-19 pandemic has caused general business disruption worldwide beginning in January 2020. The Company has experienced, and may continue to experience, an adverse impact on certain parts of its business, including a lengthening in the sales cycle for some prospective clients and delays in the delivery of professional services and training to clients. As certain clients or partners experience downturns or uncertainty in their own business operations or revenue resulting from COVID-19, the Company may continue to decrease or delay the Company’s spending, request pricing discounts, or seek renegotiations of the Company’s contracts, any of which may result in decreased revenue and cash receipts for the Company in future periods. In addition, the Company may experience client losses, including due to bankruptcy or clients ceasing operations, which may result in an inability to collect accounts receivable from these clients. The full extent to which the COVID-19 pandemic, including any new virus strains or mutations, will directly or indirectly impact the Company’s business, results of operations, cash flows, and financial condition will depend on future developments that are highly uncertain and cannot be accurately predicted.</p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Given the uncertainty regarding the length, severity, and ability to combat the COVID-19 pandemic, the Company cannot reasonably estimate the impact on its future results of operations, cash flows, or financial condition. As of the date of issuance of the financial statements, the Company is not aware of any specific event or circumstance that would require it to update its estimates, its judgments, or the carrying value of its assets or liabilities. These estimates may change as new events occur and additional information is obtained and are recognized in the financial statements as soon as they become known. Actual results could differ from those estimates, and any such differences may be material to the Company’s financial statements.</p>
CY2023	elws	Translation Description TranslationDescription	Translations of balances in the balance sheets, statements of income, statements of changes in shareholders’ equity and statements of cash flows from JPY into USD as of April 30, 2023
CY2023	elws	Currency Exchange Rate CurrencyExchangeRate	1
CY2023	elws	Currency Exchange Rate CurrencyExchangeRate	135.99
CY2023	elws	Prepayments Policy Text Bock PrepaymentsPolicyTextBock	<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration:underline">Prepayments</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Prepayments are mainly payments made to vendors or services providers for future services that have not been provided. These amounts are refundable and bear no interest. Management reviews its prepayments on a regular basis to determine if the allowance is adequate and adjusts the allowance when necessary. As of April 30, 2022 and 2023, no allowance was deemed necessary.</p>
CY2023	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering	212160121	jpy
CY2023	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering	1560116	usd
CY2023Q2	us-gaap	Deferred Costs DeferredCosts	212160121	jpy
CY2023Q2	us-gaap	Deferred Costs DeferredCosts	1560116	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther		jpy
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1397470	jpy
CY2021	us-gaap	Advertising Expense AdvertisingExpense	3132390	jpy
CY2022	us-gaap	Advertising Expense AdvertisingExpense	230000	jpy
CY2023	us-gaap	Advertising Expense AdvertisingExpense	25599131	jpy
CY2023	us-gaap	Advertising Expense AdvertisingExpense	188243	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0.50	pure
CY2022Q2	us-gaap	Accounts Receivable Gross AccountsReceivableGross	72259707	jpy
CY2023Q2	us-gaap	Accounts Receivable Gross AccountsReceivableGross	6351818	jpy
CY2023Q2	us-gaap	Accounts Receivable Gross AccountsReceivableGross	46708	usd
CY2023Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	24583098	jpy
CY2023Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	180771	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	72259707	jpy
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	30934916	jpy
CY2022Q2	us-gaap	Deposits Deposits	657418101	jpy
CY2023Q2	us-gaap	Deposits Deposits	177886393	jpy
CY2023Q2	us-gaap	Deposits Deposits	1308085	usd
CY2022Q2	us-gaap	Loans Receivable Basis Spread On Variable Rate LoansReceivableBasisSpreadOnVariableRate	0.913	pure
CY2023Q2	us-gaap	Loans Receivable Basis Spread On Variable Rate LoansReceivableBasisSpreadOnVariableRate	0.977	pure
CY2022Q2	us-gaap	Accounts Payable Interest Bearing Interest Rate AccountsPayableInterestBearingInterestRate	0.10	pure
CY2023	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	2258892	jpy
CY2023	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	16611	usd
CY2021	us-gaap	Revenues Revenues	216211448	jpy
CY2022	us-gaap	Revenues Revenues	463718851	jpy
CY2023	us-gaap	Revenues Revenues	46568529	jpy
CY2023	us-gaap	Revenues Revenues	342441	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	227479	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1595525	jpy
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3223064	jpy
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	23701	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	377440	jpy
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1156051	jpy
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	8501	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1218085	jpy
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2067013	jpy
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15200	usd
CY2021	us-gaap	Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1 AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1	67932	jpy
CY2022	us-gaap	Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1 AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1	309508	jpy
CY2023	us-gaap	Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1 AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1	778611	jpy
CY2023	us-gaap	Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1 AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1	725	usd
CY2022Q2	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	26325325	jpy
CY2023Q2	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	23307275	jpy
CY2023Q2	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	171390	usd
CY2022Q2	elws	Accrued Outsourced Development Costs Current And Noncurrent AccruedOutsourcedDevelopmentCostsCurrentAndNoncurrent	10469841	jpy
CY2022Q2	us-gaap	Accrued Sales Commission Current And Noncurrent AccruedSalesCommissionCurrentAndNoncurrent	5488150	jpy
CY2023Q2	us-gaap	Accrued Sales Commission Current And Noncurrent AccruedSalesCommissionCurrentAndNoncurrent	3934950	jpy
CY2023Q2	us-gaap	Accrued Sales Commission Current And Noncurrent AccruedSalesCommissionCurrentAndNoncurrent	28935	usd
CY2022Q2	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	7617610	jpy
CY2023Q2	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	8880909	jpy
CY2023Q2	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	65305	usd
CY2022Q2	us-gaap	Accrual For Taxes Other Than Income Taxes Current And Noncurrent AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent	1284717	jpy
CY2023Q2	us-gaap	Accrual For Taxes Other Than Income Taxes Current And Noncurrent AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent	1657172	jpy
CY2023Q2	us-gaap	Accrual For Taxes Other Than Income Taxes Current And Noncurrent AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent	12186	usd
CY2022Q2	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	545100	jpy
CY2023Q2	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	687400	jpy
CY2023Q2	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	5055	usd
CY2022Q2	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	1094468	jpy
CY2023Q2	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	2506637	jpy
CY2023Q2	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	18433	usd
CY2022Q2	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	52825211	jpy
CY2023Q2	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	47250464	jpy
CY2023Q2	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	347456	usd
CY2022Q2	us-gaap	Loans Payable LoansPayable	58668000	jpy
CY2022Q2	elws	Loan Origination Fee LoanOriginationFee	-577500	jpy
CY2022Q2	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	11769000	jpy
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	46321500	jpy
CY2023Q2	us-gaap	Loans Payable LoansPayable	192418000	jpy
CY2023Q2	us-gaap	Loans Payable LoansPayable	1414943	usd
CY2023Q2	elws	Loan Origination Fee LoanOriginationFee	-346500	jpy
CY2023Q2	elws	Loan Origination Fee LoanOriginationFee	-2548	usd
CY2023Q2	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	123819000	jpy
CY2023Q2	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	910501	usd
CY2023Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	68252500	jpy
CY2023Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	501894	usd
CY2021	us-gaap	Interest Expense InterestExpense	1232925	jpy
CY2022	us-gaap	Interest Expense InterestExpense	1045821	jpy
CY2023	us-gaap	Interest Expense InterestExpense	2346136	jpy
CY2023	us-gaap	Interest Expense InterestExpense	252	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	124050000	jpy
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	912200	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	19305000	jpy
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	141959	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	15204000	jpy
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	111802	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	15204000	jpy
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	111802	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	8687000	jpy
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	63880	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	9968000	jpy
CY2023Q2	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	73300	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	192418000	jpy
CY2023Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	1414943	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.306	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.306	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.306	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.306	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciation	-0.015	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciation	-0.007	pure
CY2022	elws	Effective Income Tax Rate Reconciliation Nondeductible Expense Nontaxable Income EffectiveIncomeTaxRateReconciliationNondeductibleExpenseNontaxableIncome	0.004	pure
CY2023	elws	Effective Income Tax Rate Reconciliation Nondeductible Expense Nontaxable Income EffectiveIncomeTaxRateReconciliationNondeductibleExpenseNontaxableIncome	0.028	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.437	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.358	pure
CY2023	elws	Effective Income Tax Rate Reconciliation Nondeductible Expense Deferred Ipo Costs EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDeferredIPOCosts	0.166	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.012	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.032	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.051	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.024	pure
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	290000	jpy
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	12963341	jpy
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-9345241	jpy
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-68720	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-15912026	jpy
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	15978261	jpy
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	122261	jpy
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	899	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-15622026	jpy
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	28941602	jpy
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-9222980	jpy
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-67821	usd
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4872262	jpy
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	175897644	jpy
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1293460	usd
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4872262	jpy
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	175897644	jpy
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1293460	usd
CY2022Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	-66235	jpy
CY2023Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	-188496	jpy
CY2023Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	-1386	usd
CY2022Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	66235	jpy
CY2023Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	188496	jpy
CY2023Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1386	usd
CY2022Q2	elws	Deferred Tax Assets Liabilitie Net DeferredTaxAssetsLiabilitieNet	-66235	jpy
CY2023Q2	elws	Deferred Tax Assets Liabilitie Net DeferredTaxAssetsLiabilitieNet	-188496	jpy
CY2023Q2	elws	Deferred Tax Assets Liabilitie Net DeferredTaxAssetsLiabilitieNet	-1386	usd
CY2019Q4	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.08	pure
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	3467368	jpy
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	25497	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3467368	jpy
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	25497	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	11695406	jpy
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	11641238	jpy
CY2021	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	10779000	jpy
CY2022	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	9567000	jpy
CY2023	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	8355000	jpy
CY2023	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	61438	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	4.4	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1035000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y9M18D
CY2023	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther		usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	3481250	jpy
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	25599	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3481250	jpy
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	25599	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	13882	jpy
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	102	usd
CY2023Q2	us-gaap	Present Value Of Future Minimum Lease Payments Sale Leaseback Transactions PresentValueOfFutureMinimumLeasePaymentsSaleLeasebackTransactions	3467368	jpy
CY2023Q2	us-gaap	Present Value Of Future Minimum Lease Payments Sale Leaseback Transactions PresentValueOfFutureMinimumLeasePaymentsSaleLeasebackTransactions	25497	usd
CY2023Q2	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	3467368	jpy
CY2023Q2	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	25497	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	8355000	jpy
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	61438	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y5M1D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.016	pure
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	603	jpy
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1035000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2
CY2023	elws	Weighted Average Remaining Contractual Term Outstanding Ending WeightedAverageRemainingContractualTermOutstandingEnding	P5Y9M18D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	603	jpy
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1035000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	2
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	603	jpy
CY2022Q2	us-gaap	Common Unit Outstanding CommonUnitOutstanding	13839400	shares
CY2023Q2	us-gaap	Common Unit Outstanding CommonUnitOutstanding	13839400	shares
CY2019Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P10Y
CY2019Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	1095000	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P10Y
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Terms Of Award ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward	1) its contractual term (i.e. 10 years after its grant date); or 2) upon the grantee terminates their employment if the vested option has not been exercised. The commencement date of exercise is upon the completion of the Company’s IPO.
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1050000	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y9M18D
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	268	jpy
CY2022	us-gaap	Stock Issued During Period Shares Share Based Compensation Forfeited StockIssuedDuringPeriodSharesShareBasedCompensationForfeited	15000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	2
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1035000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2
CY2022	elws	Weighted Average Remaining Contractual Term Outstanding Ending WeightedAverageRemainingContractualTermOutstandingEnding	P6Y9M18D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	603	jpy
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1035000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	2
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	603	jpy
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1035000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.01
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.01
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y9M18D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	4.4	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1035000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.01
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.01
CY2023	elws	Weighted Average Remaining Contractual Term Outstanding Ending WeightedAverageRemainingContractualTermOutstandingEnding	P5Y9M18D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	4.4	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1035000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	0.01
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue	2
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue	2
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue	0.01
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue	0.01
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2100000	jpy
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2070000	jpy
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2070000	jpy
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	15222	usd
CY2019Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2019Q3	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	2000000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0017	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.059	pure
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2021	us-gaap	Other Expenses OtherExpenses	56000000	jpy
CY2021Q2	us-gaap	Restructuring Reserve RestructuringReserve	56000000	jpy
CY2022	us-gaap	Other Expenses OtherExpenses	670000000	jpy
CY2022Q2	us-gaap	Restructuring Reserve RestructuringReserve	670000000	jpy
CY2023Q3	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	1200000	shares
CY2023Q3	elws	Offering Price OfferingPrice	5
CY2023Q3	elws	Aggregate Gross Proceeds AggregateGrossProceeds	6000000	usd
CY2023	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2022Q2	elws	Digital Assets DigitalAssets		jpy
CY2022Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable		jpy
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent		jpy
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		jpy
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		jpy
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		jpy
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation		jpy
CY2022	elws	Government Subsidies GovernmentSubsidies		jpy
CY2023	elws	Government Subsidies GovernmentSubsidies		jpy
CY2023	elws	Government Subsidies GovernmentSubsidies		usd
CY2021	elws	Loss On Digital Assets LossOnDigitalAssets		jpy
CY2022	elws	Loss On Digital Assets LossOnDigitalAssets		jpy
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		jpy
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		jpy
CY2022	us-gaap	Foreign Currency Transaction Gain Before Tax ForeignCurrencyTransactionGainBeforeTax		jpy
CY2021	elws	Loss On Digital Assets LossOnDigitalAssets		jpy
CY2022	elws	Loss On Digital Assets LossOnDigitalAssets		jpy
CY2021	elws	Realized Fair Value Gain On Digital Assets RealizedFairValueGainOnDigitalAssets		jpy
CY2022	elws	Realized Fair Value Gain On Digital Assets RealizedFairValueGainOnDigitalAssets		jpy
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		jpy
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		jpy
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation		jpy
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2021	elws	Increase Decrease Shortterm Deposits IncreaseDecreaseShorttermDeposits		jpy
CY2023	elws	Increase Decrease Shortterm Deposits IncreaseDecreaseShorttermDeposits		usd
CY2021	elws	Increase Decrease In Digital Assets IncreaseDecreaseInDigitalAssets		jpy
CY2022	elws	Increase Decrease In Digital Assets IncreaseDecreaseInDigitalAssets		jpy
CY2021	elws	Increase Decrease Longterm Deposits IncreaseDecreaseLongtermDeposits		jpy
CY2022	elws	Increase Decrease Longterm Deposits IncreaseDecreaseLongtermDeposits		jpy
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		jpy
CY2021	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments		jpy
CY2023	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments		jpy
CY2023	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments		usd
CY2021	elws	Refund Of Security Deposit RefundOfSecurityDeposit		jpy
CY2023	elws	Refund Of Security Deposit RefundOfSecurityDeposit		jpy
CY2023	elws	Refund Of Security Deposit RefundOfSecurityDeposit		usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		jpy
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2021	us-gaap	Payments For Proceeds From Deposit On Loan PaymentsForProceedsFromDepositOnLoan		jpy
CY2022	us-gaap	Payments For Proceeds From Deposit On Loan PaymentsForProceedsFromDepositOnLoan		jpy
CY2021	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering		jpy
CY2022	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering		jpy
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations		jpy
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations		jpy
CY2022	elws	Liabilities Assumed In Connection With Purchase Of Property And Equipment LiabilitiesAssumedInConnectionWithPurchaseOfPropertyAndEquipment		jpy
CY2023	elws	Liabilities Assumed In Connection With Purchase Of Property And Equipment LiabilitiesAssumedInConnectionWithPurchaseOfPropertyAndEquipment		jpy
CY2023	elws	Liabilities Assumed In Connection With Purchase Of Property And Equipment LiabilitiesAssumedInConnectionWithPurchaseOfPropertyAndEquipment		usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2021	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering		jpy
CY2022	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering		jpy
CY2021Q2	us-gaap	Deferred Costs DeferredCosts		jpy
CY2022Q2	us-gaap	Deferred Costs DeferredCosts		jpy
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent		usd
CY2021	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense		jpy
CY2022	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense		jpy
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable		usd
CY2022Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet		jpy
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance		pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost		pure
CY2022	elws	Effective Income Tax Rate Reconciliation Nondeductible Expense Deferred Ipo Costs EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDeferredIPOCosts		pure
CY2022Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross		jpy
CY2023Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross		jpy
CY2023Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross		usd
CY2023Q2	us-gaap	Other Long Term Debt OtherLongTermDebt		jpy
CY2023Q2	us-gaap	Other Long Term Debt OtherLongTermDebt		usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2022	elws	Weighted Average Remaining Contractual Term Grantedin Shares WeightedAverageRemainingContractualTermGrantedinShares
CY2022	elws	Weighted Average Remaining Contractual Term Forfeitedin Shares WeightedAverageRemainingContractualTermForfeitedinShares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber		shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2023	elws	Weighted Average Remaining Contractual Term Grantedin Shares WeightedAverageRemainingContractualTermGrantedinShares
CY2023	us-gaap	Stock Issued During Period Shares Share Based Compensation Forfeited StockIssuedDuringPeriodSharesShareBasedCompensationForfeited		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
CY2023	elws	Weighted Average Remaining Contractual Term Forfeitedin Shares WeightedAverageRemainingContractualTermForfeitedinShares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber		shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2023	elws	Weighted Average Remaining Contractual Term Grantedin Shares WeightedAverageRemainingContractualTermGrantedinShares
CY2023	us-gaap	Stock Issued During Period Shares Share Based Compensation Forfeited StockIssuedDuringPeriodSharesShareBasedCompensationForfeited		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
CY2023	elws	Weighted Average Remaining Contractual Term Forfeitedin Shares WeightedAverageRemainingContractualTermForfeitedinShares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber		shares
CY2023	us-gaap	Other Expenses OtherExpenses		usd
CY2023Q2	us-gaap	Restructuring Reserve RestructuringReserve		usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001944399

Files In Submission

Name	View Source	Status
0001213900-23-077074-index-headers.html	Edgar Link	pending
0001213900-23-077074-index.html	Edgar Link	pending
0001213900-23-077074.txt	Edgar Link	pending
0001213900-23-077074-xbrl.zip	Edgar Link	pending
elws-20230430.xsd	Edgar Link	pending
f20f2023ex12-1_earlyworks.htm	Edgar Link	pending
f20f2023ex12-2_earlyworks.htm	Edgar Link	pending
f20f2023ex13-1_earlyworks.htm	Edgar Link	pending
f20f2023ex13-2_earlyworks.htm	Edgar Link	pending
f20f2023ex2-3_earlyworks.htm	Edgar Link	pending
f20f2023ex4-4_earlyworks.htm	Edgar Link	pending
f20f2023ex4-7_earlyworks.htm	Edgar Link	pending
f20f2023_earlyworks.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
elws-20230430_def.xml	Edgar Link	unprocessable
elws-20230430_cal.xml	Edgar Link	unprocessable
elws-20230430_pre.xml	Edgar Link	unprocessable
elws-20230430_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
f20f2023_earlyworks_htm.xml	Edgar Link	completed
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ELWS
Earlyworks Co., Ltd. Stock $elws

2023 Q2 Form 20-F Financial Statement

#000121390023077074 Filed on September 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ELWS Earlyworks Co., Ltd. Stock $elws

2023 Q2 Form 20-F Financial Statement

#000121390023077074 Filed on September 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ELWS
Earlyworks Co., Ltd. Stock $elws